2017 ASCO-SITC Clinical Immuno-Oncology Symposium

Beyond PD-1: Harnessing Receptor Crosstalk to Overcome Immune Escape
Best Practices in Immunotherapy – June/July 2017 Vol 8
Immune checkpoint therapy, specifically PD-1 blockade, has improved survival for patients with metastatic cancer, but not all patients respond to treatment.
Loading More Articles
  • 1
  • 2
Page 2 of 2
Results 11 - 11 of 11

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
     
     
    Profession or Role
    Primary Specialty or Disease State
    Country
SUBSCRIBE

Contact Us | Editorial Board

© 2009- DBA AONN+ Academy of Oncology Nurse & Patient Navigators® PO Box 563, Cranbury, NJ 08512